Monocytes were stimulated to increase their cell surface quantity of leukocyte adhesion proteins p150,95 and Mac-i by the chemoattractant fonmyl-methionyl-leucyl-phenyblanine, or other mediators such as platelet-derived growth factor, tumor necrosis factor, C5a, and leukotriene B4. Dose-response curves indicated variations in the sensitivity of monocytes and granulocytes to these mediators. These increases were independent of protein synthesis and half-maximal at 2 min. Human alveolar and murine peritoneal macrophages, cells that had previously diapedised, could not be induced to upregulate Mac-i or p150,95. Detergent permeabilization studies in monocytes indicated that these proteins were stored in internal latent pools, which were reduced upon stimulation. Electron microscopy utilizing rabbit antiserum against p150,95 revealed these proteins on the plasma membrane, and in intracellular vesicles and peroxidase negative granules. Together with other functional studies, these findings suggest that the mobilization of Mac-i and pl50,95 from an intracellular compartment to the plasma membrane regulates the monocytes's ability to adhere and diapedese.
Introduction
In the inflammatory response blood monocytes and granulocytes bind to endothelial cells at the inflamed site, then migrate between endothelial cells and through the basement membrane into tissue. A key question is how the first step in this process, adhesion of the monocyte (or granulocyte) to the endothelial cell, is regulated. Changes in adhesiveness ofthe endothelial cell, as well as in the adhesiveness of the monocyte (or granulocyte) may both contribute to this process (1) (2) (3) (4) . Granulocyte accumulation in tissues kinetically precedes that of monocytes (1) . This has led to the idea that different mechanisms may regulate granulocyte and monocyte infiltration. However, granulocyte infiltration is not a prerequisite for monocyte infiltration, because monocyte infiltration is normal in neutropenic patients (1) .
Recently, an inherited immunodeficiency disease has been identified in which both granulocyte and monocyte diapedesis is defective (reviewed in 4, 5) . A family ofthree leukocyte adhe-C5a also induce increased Mac-I expression. Permeabilization of monocytes with detergents and immunoelectron microscopy demonstrates an intracellular vesicular compartment of Mac-I and p150,95. We propose that mobilization ofthis intracellular pool ofMac-I and p150,95 to the cell surface regulates monocyte adherence to endothelial cells, contributing to monocyte localization at inflammatory sites.
Methods
Cells. Venous blood was drawn into syringes containing 0.14 ml/ml blood of (ACD; 2 g glucose monohydrate, 1.66 g sodium citrate-5H20, 206 mg citric acid-H20, 140 mg NaH2PO4, and 17.3 mg adenine/63 ml) and in some experiments the syringes also contained 0.1 ml/ml blood of 0.1 M sodium EDTA, pH 7.2. 6% dextran T-500 (Pharmacia Fine Chemicals, Piscataway, NJ) in PBS was added to syringes giving a final dextran concentration of 1%. After 30 min at room temperature, leukocyte-rich plasma was drawn off. Cells were either stimulated immediately or prepared further as described in Results. Hypotonic lysis oferythrocytes, where indicated, was by suspension of cell pellets in icecold H20 for 25 s, followed by addition of 1/9 vol of lOX phosphatebuffered saline (PBS). Ficoll-Hypaque solutions were diluted from 16.7% Hypaque-M (Winthrop Laboratories, New York), 12.5% Ficoll 400 (Pharmacia Fine Chemicals) with H20 to desired density. In some experiments 1 mM EDTA pH 7.2 was added to Ficoll-Hypaque. Leukocyterich plasma (10-25 ml) was chilled on ice in a 50-ml tube, underlayed with 12 ml d = 1.08 Ficoll-Hypaque, 12 ml d = 1.106 Ficoll-Hypaque, and centrifuged at 1,200 g for 25 min in a centrifuge equilibrated at 4°C or -5°C. Mononuclear cells and platelets sedimented on the d = 1.08 layer and neutrophils sedimented on the d = 1.106 layer. Eosinophils and erythrocytes collected in the pellet. In some cases the d = 1.106 layer was omitted. When neutrophils were stimulated withfMLP, their density changed and they sedimented on the d = 1.08 layer, in agreement with a recent report (23) . Cells were diluted in at least 2 vol of Hanks'/ 10 mM Hepes/5 mM EDTA and washed twice at 400 g for 7 min. Platelets were collected from the mononuclear cell supernatant by centrifugation at 1,000 g for 10 min. Normal human alveolar macrophages were obtained by bronchoalveolar lavage ofhealthy subjects (nonsmokers) and generously provided by Dr. R. Rose, New England Deaconess Hospital, Boston, MA. Thioglycollate elicited mouse macrophages were collected by washing the peritoneal cavity with 10 ml of Hanks'/10 mM Hepes/10 U/ml heparnn 4 d after injection of 1. (15, 32) . Previous studies on the C3b receptor (41) Table I are averaged from three different experiments, representative histograms from which demonstrate monocyte Mac-1 and p150,95 upregulation ( Fig. 1 C, D) . Another member of the same glycoprotein family, LFA-1, showed a slight increase (Table  I, Staining with a platelet-specific MAb to glycoprotein (gp)Ib was used to assess platelet binding to monocytes and granulocytes. Platelets bound to a subpopulation of unstimulated and stimulated monocytes ( Fig. 1 E, F ) and unstimulated granulocytes (Fig. 1 I) (Fig. 2  A) . fMLP-stimulated monocyte upregulation of Mac-I and p150,95 was near maximal at 10 min and showed similar kinetics to granulocyte upregulation (Fig. 2 B) .
fMLP is an analogue of bacterial N-terminal peptides. We examined whether the results withfMLP were generalizable to other inflammatory mediators. In preliminary studies, we found that defibrination of blood resulted in four-to sixfold increased Mac-I expression on monocytes and granulocytes compared to blood collected in ACD. Defibrination activates platelets and the clotting cascade. Addition of 10% serum to leukocyte-rich plasma similarly resulted in a threefold increase in monocyte Mac-I and p150,95, while addition of platelet-poor plasma had no effect (1.0-to 1.1-fold change). This suggested PDGF released from activated platelets was the active principle. Serum stimulated similar increases in granulocyte Mac-I and p150,95.
The dose-response curves for four different inflammatory mediators, each on two to four different donors, is shown in Fig.  3 . PDGF induced Mac-I upregulation on both monocytes and granulocytes (Fig. 3 E, F) , confirming it is the factor in serum that stimulates upregulation. C5a and LTB4 stimulated modest upregulation of monocyte Mac-I of 1.7 to 2.9-fold. In contrast to other mediators tested, CSa and LTB4 had weaker effects on monocytes than on granulocytes. TNF potently stimulated marked monocyte Mac-I upregulation ( Fig. 3 G) ; higher concentrations were required to stimulate granulocyte Mac-i upregulation (Fig. 3 H) . In these studies, we found differences between donors in the extent of monocyte Mac-i upregulation; differences were more marked for monocytes than for granulocytes and were consistently found in independent experiments. Donor-dependent differences of severalfold in the extent of monocyte Mac-I upregulation were also found withfMLP (not shown).
We IMac-1, gran into the supernatant and increased accessibility of Mac-i and p150,95 to MAbs suggested permeabilization was maximal at 0.03-0.1% Triton X-100 (Fig. 4) . Immunoprecipitation of Mac-1 from supernatants of permeabilized cells suggested that 0.1% Triton X-100 released only small amounts (5-15%) of Mac-l (data not shown).
The effect of stimulation with fMLP and permeabilization with 0.1% Triton X-100 on antibody-accessible antigen was then examined for both monocytes and granulocytes (Table H) .fMLP stimulated a large increase in monocyte cell surface Mac-I and p150,95 (13.9 and 9.5-fold, respectively). When cells not incubated withfMLP were permeabilized with Triton X-100, a large latent pool of Mac-I and p150,95 became accessible, as shown by 12.5-and 8. Parallel studies on granulocytes demonstrated a similar detergent accessible pool (Table II) . However, more Mac-I could be accessed after Triton X-100 permeabilization than was mobilized byfMLP. This effect was consistently seen in other experiments, suggesting that mobilization by fMLP of the intracellular pools of these antigens in granulocytes was incomplete.
For comparison, LFA-I and HLA-A,B were examined. On monocytes, the amount of LFA-I accessible to MAb showed a modest increase (twofold) after detergent permeabilization or stimulation with fMLP. LFA-I was not increased on granulocytes. There was little or no latent pool ofHLA-A,B in monocytes and granulocytes.
To verify the intracellular location of Mac-I and p 150,95 in monocytes, they were subjected to immunogold staining and electron microscopy. An antiserum against immunoaffinity purified p 150,95 protein was raised in rabbits. To remove any reac- with Mac-I and LFA-l (40a) and therefore detected Mac-i, LFA-1, and p150,95. Nichols and 3ainton (39) had previously demonstrated that human blood monocytes contain two distinct populations of granules, peroxidase-positive and peroxidasenegative, in approximately equal numbers. Fig. 5 shows the localization of this family of proteins on a frozen thin section of a normal human blood monocyte that had initially been reacted for peroxidase. Label was present in peroxidase-negative vacuoles, some of which may be granules, and on the plasma membrane. Smaller quantities were found on perinuclear cisternae, and the Golgi cisternae (not illustrated) occasionally contained label. The dense peroxidase-positive granules did not contain immunogold label. Negligible gold labeling was found when the primary antiserum was replaced by normal rabbit serum.
The above studies were done on cells from blood. Since the latent pool ofMac-I and p 150,95 might be mobilized and hence exhausted during extravasation, we examined tissue macrophages. Human alveolar macrophages were obtained by bronchoalveolar lavage from a healthy subject. Mouse thioglycollateelicited peritoneal macrophages were obtained through peritoneal lavage. Cell surface antigens were quantitated with murine MAb to human Mac-i, p 150,95, LFA-1, and HLA-A,B and rat MAb to mouse Mac-I and H-2KD (Table III) . Human alveolar macrophages had more p150,95 than Mac-i, consistent with previous reports that the relative quantities of these two antigens are reversed during differentiation ofmonocytes to tissue macrophages (26, 44) . Incubation with 10-7fMLP resulted in no change in surface Mac-I or p150,95 on both human and murine macrophages (Table III) . Tissue macrophages have previously been shown to havefMLP receptors and to chemotax tofMLP (17), but in case they were not functionally active in stimulating Mac-1 upregulation, we used PMA, which bypasses surface receptors by acting directly on protein kinase C. PMA has previously been shown to be a potent stimulant of increased granulocyte cell surface Mac-i (45) . PMA stimulated only a very slight (1.2-fold) increase in murine macrophage surface Mac-I and no increase in human alveolar macrophage Mac-i or p150,95 (Table III) . Similar to thioglycollate broth-elicited peritoneal macrophages, resident murine peritoneal macrophages were found not to increase surface Mac-I after stimulation with fMLP or phorbol myristate acetate (PMA) (not shown).
Discussion
We have shown that stimulation ofblood monocytes withfMLP induces a rapid increase in cell surface expression oftwo adhesion proteins, Mac-I and p150,95. The increases over basal levels of expression are very striking, in the range of 4-to 12-fold. The LFA-l antigen on monocytes was consistently, but less strikingly increased after fMLP stimulation by 1.6-to 2-fold. The Immunogold labeling of thin sections and visualization in the electron microscope has verified that monocytes contain Mac-I and p150,95 in intracellular vesicles that are peroxidasenegative. Blood monocytes have previously been shown to contain both peroxidase-positive and peroxidase-negative granules (39) . The peroxidase-negative vesicles shown here to contain Mac-i family glycoproteins may correspond to the previously defined peroxidase-negative granules, but this point requires further study. The peroxidase-negative granules appear late in maturation of promonocytes in bone marrow, being preceded by formation of peroxidase-positive granules. Whether these granules in monocytes are analogous to the specific, or secondary, granules of neutrophils, a reported intracellular storage site for Mac-I (16) , is unclear.
The importance of Mac-i, and to a lesser extent p150,95, has been demonstrated in a wide variety ofgranulocyte adhesion reactions (reviewed in 46). fMLP and other agents including CSa, leukotriene B4, platelet activating factor, LPS, and TNF stimulate increased granulocyte surface expression of Mac-I and p150,95 (1, 5, 10, 14, 21, 45) . This correlates with increased (hyper-) adherence to endothelial cells, adherence and spreading on artificial substrates, and granulocyte homotypic aggregation (5, 47, 48) . These adherence functions are inhibited by MAb to the common beta subunit of Mac-1, p150,95, and LFA-1, to the Mac-I alpha subunit, and to a lesser extent to the p150,95 alpha subunit (8, 11, 13) . Furthermore, genetically deficient patient granulocytes that lack intracellular and surface Mac-I and p150,95 show depressed baseline adherence and a lack ofJMLPstimulated hyperadherence and aggregation (5, 8, 9, 48) .
Less is known about the importance of these molecules on monocytes, primarily because ofthe greater difficulty of obtaining purified blood monocytes. However, monocytes from patients genetically deficient in Mac-i, p150,95, and LFA-1 show diminished adherence to endothelial cells and diminished chemotaxis; MAb to the common beta subunit ofthese glycoproteins block adherence by normal monocytes (7, 9) . These findings suggest that the Mac-i, p150,95 and LFA-l glycoprotein family mediates monocyte adherence to endothelial cells, and the findings presented here suggest that adherence is regulated by mobilization of intracellular Mac-i, p150,95, and possibly LFA-1.
Mac-I has a dual function as a receptor for iC3b and as an adhesion protein (4, 13, 46) . Solubilized p150,95 binds to iC3b (49) and also may function as an adhesion protein (13) . Upregulation of these molecules should enhance complement-dependent monocyte effector functions, as has been demonstrated by Yancey et al. (22) . Binding ofmonocytes to fibronectin-coated surfaces stimulates iC3b-mediated phagocytosis without affecting the number of Mac-I (iC3b) receptors (50) . Thus, stimulated upregulation ofMac-i, and binding ofmonocytes to fibronectin in the extracellular matrices underlying endothelial cells, provide two independent mechanisms for enhancing monocyte complement receptor function during extravasation.
We found thatfMLP-stimulated increases in the Mac-I and p150,95 adhesion proteins were similar in monocytes and granulocytes, although LFA-l was increased in monocytes but not in granulocytes. Detergent permeabilization demonstrated latent, intracellular Mac-I and p150,95 in both cell types. This suggests that adhesiveness in granulocytes and monocytes is regulated by similar mechanisms. The importance of these glycoproteins in diapedesis of both types of cells is further supported by lack of exudation of both monocytes and granulocytes in Mac-l/ pI50,95/LFA-l-deficient patients (5, 51) .
We propose that at sites ofinflammation, mediators diffusing into the blood stream stimulate increased monocyte surface expression of Mac-l and p50O,95, leading to adherence to endothelial cells and localization at the inflammatory site. Upregulation in vivo may be initially less complete than at the saturating concentrations of mediators used here, and continued upregulation of Mac-I and p150,95 during diapedesis may help mediate extravasation. Differences between monocytes and granulocytes in the dose of mediator required for Mac-l upregulation, most notably in the 10-to 100-fold greater sensitivity of monocytes to TNF, may have important consequences for determining which cell type predominates in inflammatory infiltrates in vivo.
Monocytes cross the endothelium just once in their life history, and then differentiate into the diverse cells of the mononuclear phagocyte system. During differentiation, the amount of p 50,95 expression increases (25, 26) . Human alveolar macrophages express higher baseline levels of these antigens, and lack mobilizable Mac-I and p150,95. Mouse peritoneal macrophagessimilarly lack mobilizable Mac-1. These findingssuggest that intracellular pools of Mac-i and p150,95 are lost during extravasation. The secretory pool ofMac-and p 150,95 appears to be a specialized feature of circulating monocytes, of importance in crossing the endothelial barrier.
